Reshma Rangwala
Chief Tech/Sci/R&D Officer presso KARYOPHARM THERAPEUTICS INC.
Patrimonio netto: 517 826 $ in data 31/03/2024
Profilo
Reshma Rangwala is currently the Chief Medical Officer & Executive Vice President at Karyopharm Therapeutics, Inc. Prior to this, she held positions as the Executive Clinical Director at Merck & Co., Inc. from 2012 to 2017, Vice President-Medical at Genmab, Inc. from 2017 to 2020, and Chief Medical Officer at Aravive, Inc. from 2020 to 2022.
Dr. Rangwala completed her undergraduate degree at Duke University and obtained her doctorate from The University of Cincinnati College of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/04/2024 | 342 931 ( 0.30% ) | 517 826 $ | 31/03/2024 |
Posizioni attive di Reshma Rangwala
| Società | Posizione | Inizio |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Precedenti posizioni note di Reshma Rangwala
| Società | Posizione | Fine |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 28/03/2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
Formazione di Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Reshma Rangwala
